Structure
The seminal vesicles are a pair of glands in males that are positioned below the urinary bladder and at the end of the vasa deferentia, where they enter the prostate. Each vesicle is a coiled and folded tube, with occasional outpouchings termed diverticula in its wall. The lower part of the tube ends as a straight tube called the excretory duct which joins with the vas deferens of that side of the body to form an ejaculatory duct. The ejaculatory ducts pass through the prostate gland before opening separately into the verumontanum of the prostatic urethra. The vesicles are between 5–10 cm in size, 3–5 cm in diameter, and have a volume of around 13 mL.The vesicles receive blood supply from the vesiculodeferential artery, and also from the inferior vesical artery. The vesiculodeferential artery arises from the umbilical arteries, which branch directly from the internal iliac arteries. Blood is drained into the vesiculodeferential veins and the inferior vesical plexus, which drain into the internal iliac veins. Lymphatic drainage occurs along the venous routes, draining into the internal iliac nodes.The vesicles lie behind the bladder at the end of the vasa deferentia. They lie in the space between the bladder and the rectum; the bladder and prostate lie in front, the tip of the ureter as it enters the bladder above, and Denonvilliers fascia and the rectum behind. Development
In the developing embryo, at the hind end lies a cloaca.
Prevention
Presbycusis is the leading cause of SNHL and is progressive and nonpreventable, and at this time, we do not have either somatic or gene therapy to counter heredity-related SNHL. But other causes of acquired SNHL are largely preventable, especially nosocusis type causes. This would involve avoiding environmental noise, and traumatic noise such as rock concerts and nightclubs with loud music. Use of noise attenuation measures like ear plugs is an alternative, as well as learning about the noise levels one is exposed to. Currently, several accurate sound level measurement apps exist. Reducing exposure time can also help manage risk from loud exposures. Treatment
Treatment modalities fall into three categories: pharmacological, surgical, and management. As SNHL is a physiologic degradation and considered permanent, there are as of this time, no approved or recommended treatments. There have been significant advances in identification of human deafness genes and elucidation of their cellular mechanisms as well as their physiological function in mice. Nevertheless, pharmacological treatment options are very limited and clinically unproven. Such pharmaceutical treatments as are employed are palliative rather than curative, and addressed to the underlying cause if one can be identified, in order to avert progressive damage. Profound or total hearing loss may be amenable to management by cochlear implants, which stimulate cochlear nerve endings directly. A cochlear implant is surgical implantation of a battery powered electronic medical device in the inner ear.